Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Accumulated Expenses: 2009-2025

Historic Accumulated Expenses for Innoviva (INVA) over the last 17 years, with Sep 2025 value amounting to $21.6 million.

  • Innoviva's Accumulated Expenses rose 22.77% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year increase of 22.77%. This contributed to the annual value of $30.0 million for FY2024, which is 52.29% up from last year.
  • Innoviva's Accumulated Expenses amounted to $21.6 million in Q3 2025, which was down 43.12% from $38.0 million recorded in Q2 2025.
  • Innoviva's 5-year Accumulated Expenses high stood at $38.0 million for Q2 2025, and its period low was $1.7 million during Q1 2021.
  • For the 3-year period, Innoviva's Accumulated Expenses averaged around $16.4 million, with its median value being $17.6 million (2024).
  • Per our database at Business Quant, Innoviva's Accumulated Expenses dropped by 20.19% in 2023 and then spiked by 796.08% in 2025.
  • Innoviva's Accumulated Expenses (Quarterly) stood at $4.2 million in 2021, then skyrocketed by 93.21% to $8.0 million in 2022, then spiked by 145.55% to $19.7 million in 2023, then spiked by 52.29% to $30.0 million in 2024, then increased by 22.77% to $21.6 million in 2025.
  • Its Accumulated Expenses was $21.6 million in Q3 2025, compared to $38.0 million in Q2 2025 and $30.7 million in Q1 2025.